metformin and 4-nitrobenzylthioinosine

metformin has been researched along with 4-nitrobenzylthioinosine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davidson, SM; Gonçalves, L; Hausenloy, DJ; Mocanu, MM; Monteiro, P; Paiva, M; ProvidĂȘncia, L; Riksen, NP; Rongen, GA; Smits, P; Yellon, DM1
Allwood, JW; Beall, C; Lees, Z; Logie, L; McDougall, G; Rena, G1

Other Studies

2 other study(ies) available for metformin and 4-nitrobenzylthioinosine

ArticleYear
Metformin prevents myocardial reperfusion injury by activating the adenosine receptor.
    Journal of cardiovascular pharmacology, 2009, Volume: 53, Issue:5

    Topics: Adenosine; Animals; Biological Transport; Hypoglycemic Agents; In Vitro Techniques; Male; Metformin; Myocardial Infarction; Myocardial Reperfusion Injury; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Theophylline; Thioinosine

2009
Regulation of hepatic glucose production and AMPK by AICAR but not by metformin depends on drug uptake through the equilibrative nucleoside transporter 1 (ENT1).
    Diabetes, obesity & metabolism, 2018, Volume: 20, Issue:12

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Biological Transport; Equilibrative Nucleoside Transporter 1; Female; Glucose; Hepatocytes; Hypoglycemic Agents; Liver; Metformin; Mice; Phosphorylation; Ribonucleotides; Signal Transduction; Thioinosine

2018